Drug · DIN 02372010
JALYN
MODIFIED-RELEASE CAPSULE (DUTASTERIDE: IMMEDIATE RELEASE, AND TAMSULOSIN HCL: EXTENDED RELEASE)
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 17, 2011; first marketed November 17, 2011.
- Drug Identification Number (DIN)
- 02372010
- Company (DIN owner)
- Glaxosmithkline IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule (Immediate- And Extended-Release
- Route
- Oral
- Therapeutic class (ATC)
- Tamsulosin and dutasteride G04CA52
- Class
- Human
- Record last updated
- September 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DUTASTERIDE | 0.5 MG | |
| TAMSULOSIN HYDROCHLORIDE | 0.4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 15, 2011: NOC 12551New Drug Submission (NDS)